In this jointly hosted webinar, you will:

• Hear how Twist Biopharma, a division of Twist Bioscience, has developed a proprietary platform that uses Twist’s high-throughput DNA synthesis to produce and discover highly specific antibodies.
• Learn how this platform has been used to discover over 100 high-affinity antibodies to the SARS-CoV-2 spike protein.
• See how Twist is using the Carterra LSA high throughput surface plasmon resonance (SPR) platform to bypass ELISA screening and proceed directly to binding kinetics and epitope binning after panning, thereby consolidating mAb workflows and reducing time to results.
• Learn how to survey the epitope landscape of your antibody library at the earliest stages of discovery.